This comprehensive study assessed the impact of minor relative changes in peptide length and sequence for the induction CD8+ T cell responses in HLA-A2.1 transgenic mice to antigens relevant to the development of gynecological cancer vaccines, based on the lead vaccine antigens HPVE7, Survivin and WT1. The gene discussed is WT1; the disease is female reproductive organ cancer.